课题基金 / 基金详情

Akt phosphorylation and arrhythmogenic modification of the cardiac sodium channel

Akt phosphorylation and arrhythmogenic modification of the cardiac sodium channel
Akt 磷酸化和心脏钠通道的致心律失常修饰
批准号:
18590757
负责人:
MAKITA Naomasa
金额:
$2.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

MAKITA Naomasa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Akt is a serine-threonine phosphatase implicated in wide variety of signal transductions including cell proliferation and apoptosis. Selective overexpression of Akt in mice heart results in cardiac hypertrophy, but occasionally, some transgenic mice die suddenly with unknown causes before the cardiac hypertrophy is fully established, suggesting life-threatening arrhythmias during Akt-induction. The purpose of the study was to elucidate the biophysical and biochemical mechanisms underlying Akt-induced cardiac hypertrophy and lethal arrhythmias. We focused on cardiac Na channel Navl.5, because Navl.5, unlike other cardiac ion channels, has two Akt phosphorylation recognition sequences (RXRXXT/S). Navl.5 was coexpressed in HEK 293 cells together with Akt or its phosphorylation deficient mutant Akt-3A (K179A+T308A+S478A), and the biophysical properties were determined by whole-cell patch clamp technique. Current density of Nav.15 was significantly increased by Akt but not by Akt-3A. Voltage-dependence of the activation curve, but not inactivation, was significantly shifted in the depolarizing direction. Furthermore, coimmunoprecipitation of FLAG-tagged Nav.15 with anti-phosphorylated-Akt antibodies revealed that Akt but not Akt-3A increased the association of Akt with cardiac Na channel. These results suggest that Akt modified the biophysical properties and expression levels of Na channel, leading to induce of lethal arrhythmias. Further study including in vivo ECG recording in Aid transgenic mice are required to elucidate the mechanistic link between cardiac Akt signaling pathway and the lethal arrhythmias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
心筋Naチャネル病
心脏钠离子通道疾病
DOI: --
发表时间: 2006
期刊: 医学の歩み 217
影响因子: --
作者: [蒔田直昌, ら]
通讯作者:
Left Ventricular Noncompaction Associated With Mutations in Cardiac Na Channel Gene SCN5A
左心室致密化不全与心脏 Na 通道基因 SCN5A 突变相关
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Makita N. , et. al., 蒔田直昌, 蒔田直昌, 蒔田直昌, Makita N, Makita N]
通讯作者: Makita N
DOI: 10.1253/circj.72.1018
发表时间: 2008-06-01
期刊: CIRCULATION JOURNAL
影响因子: 3.3
作者: [Makita, Naomasa, Mochizuki, Naoki, Tsutsui, Hiroyuki]
通讯作者: Tsutsui, Hiroyuki
DOI: 10.1172/jci30651
发表时间: 2007-07-01
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Nakaoka, Yoshikazu, Nishida, Keigo, Mochizuki, Naoki]
通讯作者: Mochizuki, Naoki
24
    Novel molecular basis underlying lethal arrhythmic syndrome due to mutations in cardiac Na/Ca exchanger gene
    Novel molecular basis of cardriac conduction disturbance associated with a collagene gene mutation
    • 批准号:
      15K15311
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      MAKITA Naomasa
    • 依托单位:
    Elucidation of novel pathophysiology underlysing lethal arrhythmia due to mutations in cardiac ion transporters
    • 批准号:
      15H04823
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2015
    • 负责人:
      MAKITA Naomasa
    • 依托单位:
    Identification of Novel Genes and Pathogenesis Responsible for Brugada Syndrome Using Whole Exome Sequencing
    • 批准号:
      24390199
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2012
    • 负责人:
      MAKITA Naomasa
    • 依托单位:
    国内基金
    海外基金
    SENP5调控磷酸化STAT2的SUMO修饰促进抗病毒天然免疫的机制研 究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      胡源
    • 依托单位:
    酪氨酸磷酸酶SHP1新型作用底物THEMIS的鉴定及其在免疫T细胞发育过程中的功能探究
    • 批准号:
      32070776
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      范高峰
    • 依托单位:
    MG53蛋白的翻译后修饰调节及其应用研究
    • 批准号:
      31970722
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      吕凤祥
    • 依托单位:
    ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
    • 批准号:
      91957109
    • 项目类别:
      重大研究计划
    • 资助金额:
      79.0万元
    • 批准年份:
      2019
    • 负责人:
      黄赞
    • 依托单位: